{"title":"Evaluation of Scientific Publications on Osteoblastoma Published between 2000 and 2022","authors":"Selçuk YILMAZ, Mehmet KURT","doi":"10.16899/jcm.1317474","DOIUrl":null,"url":null,"abstract":"Objective: The aim of this bibliometric study was to review the scientific outputs published between 2000 and 2022 on osteoblastoma, a benign aggressive bone tumor.
 Methods: Scientific research articles on osteoblastoma published between 2000 and 2022 were targeted and data were obtained from the Web of Science database. The data obtained were analyzed and visualized using bibliometric programs.
 Results: A total of 679 articles about osteoblastoma published between 2000-2022 met our inclusion criteria. Most of the articles on osteoblastoma (n=48) were published in 2020. There was no noteworthy peak in the trend of the number of publications between 2000 and 2022. These articles cited 10366 times in total and 15.27 times per article. At least 62 various countries and regions took part in osteoblastoma publishing research over the past 22 years. The United States (192) was the largest contributor to osteoblastoma publications followed by China (60), India (51), Italy (50), and Turkey (46). The United States was the country that published the most publications in all years between 2000 and 2022. Especially China's publications increased in 2022. The United States was also the country with the highest level of publication collaboration (such as citation and co-authorship) among countries.
 Conclusion: The number of published articles is well below the expected level. Although the number of scientific publications from China has increased in recent years, the United States still ranks first.","PeriodicalId":15449,"journal":{"name":"Journal of contemporary medicine","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of contemporary medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.16899/jcm.1317474","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The aim of this bibliometric study was to review the scientific outputs published between 2000 and 2022 on osteoblastoma, a benign aggressive bone tumor.
Methods: Scientific research articles on osteoblastoma published between 2000 and 2022 were targeted and data were obtained from the Web of Science database. The data obtained were analyzed and visualized using bibliometric programs.
Results: A total of 679 articles about osteoblastoma published between 2000-2022 met our inclusion criteria. Most of the articles on osteoblastoma (n=48) were published in 2020. There was no noteworthy peak in the trend of the number of publications between 2000 and 2022. These articles cited 10366 times in total and 15.27 times per article. At least 62 various countries and regions took part in osteoblastoma publishing research over the past 22 years. The United States (192) was the largest contributor to osteoblastoma publications followed by China (60), India (51), Italy (50), and Turkey (46). The United States was the country that published the most publications in all years between 2000 and 2022. Especially China's publications increased in 2022. The United States was also the country with the highest level of publication collaboration (such as citation and co-authorship) among countries.
Conclusion: The number of published articles is well below the expected level. Although the number of scientific publications from China has increased in recent years, the United States still ranks first.